Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Angle Plc ADR (OP:ANPCY)

0.3873 +0.0497 (+14.72%)
Streaming Delayed Price Updated: 10:54 AM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Angle Plc ADR

< Previous 1 2 3 4 5 6 Next >
Angle PLC Announces Board Changes
Via ACCESS Newswire
Angle PLC Announces Interim Results
Via ACCESS Newswire
Angle PLC Announces Change of Adviser
Via ACCESS Newswire
Angle PLC Announces Notice of Results
Via ACCESS Newswire
ANGLE Announces Collaboration with Myriad Genetics
Via ACCESS Newswire
Angle PLC Announces Parsortix Enables Study Of Cancer Progression
Via ACCESS Newswire
Angle PLC Announces Preliminary Results
Via ACCESS Newswire
Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay
Via ACCESS Newswire
Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich
Via ACCESS Newswire
ANGLE PLC Announces Result of 2025 Annual General Meeting
Via ACCESS Newswire
Angle PLC - EACR 2025: Innovation in AR Expression Profiling
Via ACCESS Newswire
Angle PLC - EACR 2025: Data Demonstrating DNA Dual Analysis
Via ACCESS Newswire
ANGLE plc Announces Novel Discoveries Into the Biology of Cancer
Via ACCESS Newswire
Angle PLC Announces Posting of Annual Report and Notice of AGM
Via ACCESS Newswire
Angle PLC Announces Board Changes
Via ACCESS Newswire
Angle PLC Announces Trading Update
Via ACCESS Newswire
Angle PLC Announces HER2 Presentation at SABCS
Via ACCESSWIRE
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
Via ACCESSWIRE
Angle PLC Announces Issue of LTIP Options and Share Options
Via ACCESS Newswire
Angle PLC Announces Results of Eisai Phase 2 pilot study
Via ACCESS Newswire
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
Via ACCESSWIRE
Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
Via ACCESSWIRE
Angle PLC Announces 100th Publication Supporting Parsortix System Use
Via ACCESSWIRE
Angle PLC Announces Half-year Report
Via ACCESSWIRE
Angle PLC Announces Exclusive agreement for DNA NGS panel
Via ACCESSWIRE
Angle PLC Announces Agreement with Recursion Pharmaceuticals
Via ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
Via ACCESSWIRE
Angle PLC - Data Supporting FDA Approval Published in Journal
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.